美国 · SEC FORM 4
Zivo Bioscience, Inc.
ZIVO · OTC · CIK 0001101026 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
0 同一窗口内观察到的 Form 4 交易行
0 sales · 0 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
当前 180 天窗口内没有 Form 4 交易事件。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
最新留档分数
- 40.8
- 41.8
- 41.8
- 41.8
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- +47.2%
- 3M
- +9.7%
- 6M
- +120.8%
- 12M
- -55.8%
波动率与流动性
- 波动率
- 152.4%
- Beta
- —
- 平均每日成交额
- USD 3,029
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- —
- ROE
- —
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 7,977
- 上期报告
- 8,019
- 日均成交量
- 1,137
- 回补天数
- 7.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-04-17 | STROME GROUP, INC.; STROME INVESTMENT MANAGEMENT LP; STROME MARK E | 买入 (P) | Common Stock | 100,000 | USD 2.00 | USD 200,000 | SEC 申报 ↗ |
| 2026-02-27 | YALDOO LAITH L | 买入 (P) | Common Stock | 1,543 | USD 9.72 | USD 14,998 | SEC 申报 ↗ |
| 2026-02-12 | STROME GROUP, INC.; STROME INVESTMENT MANAGEMENT LP; STROME MARK E | 买入 (P) | Common Stock | 20,000 | USD 9.77 | USD 195,400 | SEC 申报 ↗ |
| 2026-02-10 | YALDOO LAITH L | 买入 (P) | Common Stock | 2,434 | USD 10.27 | USD 24,997 | SEC 申报 ↗ |
| 2026-01-26 | PAYNE JOHN BERNARD | 买入 (P) | Common Stock | 11,709 | USD 8.54 | USD 99,995 | SEC 申报 ↗ |
| 2026-01-26 | Cornell Alison A | 买入 (P) | Common Stock | 11,709 | USD 8.54 | USD 99,995 | SEC 申报 ↗ |
| 2026-01-14 | YALDOO LAITH L | 买入 (P) | Common Stock | 1,766 | USD 8.49 | USD 14,993 | SEC 申报 ↗ |
| 2026-01-14 | Maggiore Christopher D. | 买入 (P) | Common Stock | 1,766 | USD 8.49 | USD 14,993 | SEC 申报 ↗ |
| 2025-11-28 | YALDOO LAITH L | 买入 (P) | Common Stock | 2,777 | USD 9.00 | USD 24,993 | SEC 申报 ↗ |
| 2025-10-13 | STROME GROUP, INC.; STROME INVESTMENT MANAGEMENT LP; STROME MARK E | 买入 (P) | Common Stock | 20,259 | USD 12.34 | USD 249,996 | SEC 申报 ↗ |
| 2025-10-10 | YALDOO LAITH L | 买入 (P) | Common Stock | 1,659 | USD 12.05 | USD 19,991 | SEC 申报 ↗ |
| 2025-10-08 | Maggiore Christopher D. | 买入 (P) | Common Stock | 23,682 | USD 12.01 | USD 284,421 | SEC 申报 ↗ |
| 2025-09-30 | YALDOO LAITH L | 买入 (P) | Common Stock | 15,322 | USD 15.99 | USD 244,999 | SEC 申报 ↗ |
| 2025-06-13 | YALDOO LAITH L | 买入 (P) | Common Stock | 3,488 | USD 14.33 | USD 49,983 | SEC 申报 ↗ |
| 2025-01-22 | YALDOO LAITH L | 买入 (P) | Common Stock | 10,080 | USD 17.53 | USD 176,702 | SEC 申报 ↗ |
Form 4 申报证据
9 transaction lines in the latest 365-day window; 80 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-04-17 | STROME GROUP, INC.; STROME INVESTMENT MANAGEMENT LP; STROME MARK E | 买入 (P) | Common Stock | 100,000 | USD 2.00 | USD 200,000 | SEC 申报 ↗ |
| 2026-02-27 | YALDOO LAITH L | 买入 (P) | Common Stock | 1,543 | USD 9.72 | USD 14,998 | SEC 申报 ↗ |
| 2026-02-12 | STROME GROUP, INC.; STROME INVESTMENT MANAGEMENT LP; STROME MARK E | 买入 (P) | Common Stock | 20,000 | USD 9.77 | USD 195,400 | SEC 申报 ↗ |
展开近期 Form 4 证据 (9 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-04-17 | STROME GROUP, INC.; STROME INVESTMENT MANAGEMENT LP; STROME MARK E | 买入 (P) | Common Stock | 100,000 | USD 2.00 | USD 200,000 | SEC 申报 ↗ |
| 2026-02-27 | YALDOO LAITH L | 买入 (P) | Common Stock | 1,543 | USD 9.72 | USD 14,998 | SEC 申报 ↗ |
| 2026-02-12 | STROME GROUP, INC.; STROME INVESTMENT MANAGEMENT LP; STROME MARK E | 买入 (P) | Common Stock | 20,000 | USD 9.77 | USD 195,400 | SEC 申报 ↗ |
| 2026-02-10 | YALDOO LAITH L | 买入 (P) | Common Stock | 2,434 | USD 10.27 | USD 24,997 | SEC 申报 ↗ |
| 2026-01-26 | PAYNE JOHN BERNARD | 买入 (P) | Common Stock | 11,709 | USD 8.54 | USD 99,995 | SEC 申报 ↗ |
| 2026-01-26 | Cornell Alison A | 买入 (P) | Common Stock | 11,709 | USD 8.54 | USD 99,995 | SEC 申报 ↗ |
| 2026-01-14 | YALDOO LAITH L | 买入 (P) | Common Stock | 1,766 | USD 8.49 | USD 14,993 | SEC 申报 ↗ |
| 2026-01-14 | Maggiore Christopher D. | 买入 (P) | Common Stock | 1,766 | USD 8.49 | USD 14,993 | SEC 申报 ↗ |
| 2025-11-28 | YALDOO LAITH L | 买入 (P) | Common Stock | 2,777 | USD 9.00 | USD 24,993 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ZIVO |
| CIK | 0001101026 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | OTC |
数据覆盖
| 本地 Form 4 历史 | 80 transaction lines from 2020-01-03 to 2026-04-17 49 P purchase lines · 1 S sale lines · 30 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.